Brickell Average Equity vs Earnings before Tax Analysis
BBI Stock | USD 0.90 0.01 1.10% |
Trend analysis of Brickell Biotech balance sheet accounts such as Short Long Term Debt Total of 75.4 K, Other Current Liabilities of 3.8 M or Total Current Liabilities of 6.8 M provides information on Brickell Biotech's total assets, liabilities, and equity, which is the actual value of Brickell Biotech to its prevalent stockholders. By breaking down trends over time using Brickell Biotech balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Brickell |
About Brickell Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Brickell Biotech at a specified time, usually calculated after every quarter, six months, or one year. Brickell Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Brickell Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Brickell currently owns. An asset can also be divided into two categories, current and non-current.
Brickell Biotech Balance Sheet Chart
Brickell Biotech Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Brickell Biotech uses and utilizes its capital. It also shows what exactly a company owns and owes.
As of now, Brickell Biotech's Cash And Short Term Investments are decreasing as compared to previous years. The Brickell Biotech's current Common Stock Shares Outstanding is estimated to increase to about 2.2 M, while Total Assets are projected to decrease to under 32.5 M. Add Fundamental
Total Assets
Total assets refers to the total amount of Brickell Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Brickell Biotech books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Brickell Biotech balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Brickell Biotech are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most indicators from Brickell Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Brickell Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brickell Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.The current Selling General Administrative is estimated to decrease to about 10.6 M. The current Issuance Of Capital Stock is estimated to decrease to about 22.7 M
2023 | 2024 (projected) | Total Operating Expenses | 46.7M | 29.0M | Cost Of Revenue | 23.2M | 24.4M |
Brickell Biotech fundamental ratios Correlations
Click cells to compare fundamentals
Brickell Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Brickell Biotech fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 52.3M | 18.1M | 33.6M | 29.7M | 34.2M | 32.5M | |
Other Current Liab | (1.5M) | 6.4M | 5.4M | 3.1M | 3.6M | 3.8M | |
Total Current Liabilities | 3.6M | 10.5M | 6.4M | 4.8M | 5.5M | 6.8M | |
Total Stockholder Equity | 48.8M | 7.6M | 27.1M | 24.9M | 28.6M | 27.2M | |
Property Plant And Equipment Net | 100K | 175K | 104K | 117K | 134.6K | 127.8K | |
Net Debt | (7.2M) | (7.1M) | (29.6M) | (26.8M) | (24.1M) | (25.3M) | |
Retained Earnings | (442.1M) | (85.0M) | (105.9M) | (145.4M) | (130.8M) | (137.4M) | |
Accounts Payable | 412K | 2.2M | 568K | 1.6M | 1.4M | 1.6M | |
Cash | 11.9M | 7.2M | 30.1M | 26.9M | 30.9M | 21.3M | |
Non Current Assets Total | 3.1M | 175K | 104K | 117K | 134.6K | 127.8K | |
Cash And Short Term Investments | 48.1M | 11.7M | 30.1M | 26.9M | 30.9M | 51.3M | |
Common Stock Shares Outstanding | 69.3K | 67.2K | 544.8K | 1.8M | 2.1M | 2.2M | |
Liabilities And Stockholders Equity | 52.3M | 18.1M | 33.6M | 29.7M | 34.2M | 32.5M | |
Non Current Liabilities Total | 1.7M | 73K | 146K | 1.7M | 1.5M | 1.6M | |
Other Stockholder Equity | 490.3M | 74.4M | 132.5M | 169.1M | 194.4M | 255.6M | |
Total Liab | 3.6M | 10.6M | 6.5M | 4.8M | 5.5M | 8.9M | |
Property Plant And Equipment Gross | 606K | 100K | 175K | 104K | 119.6K | 113.6K | |
Total Current Assets | 49.2M | 18.0M | 33.5M | 29.6M | 34.0M | 62.7M | |
Short Term Debt | 4.6M | 78K | 365K | 69K | 79.4K | 75.4K | |
Other Current Assets | 1.1M | 6.2M | 3.4M | 2.7M | 2.4M | 2.3M | |
Net Tangible Assets | 48.8M | 7.6M | 27.1M | 24.9M | 22.4M | 36.3M | |
Retained Earnings Total Equity | (426.7M) | (442.1M) | (85.0M) | (105.9M) | (121.8M) | (127.9M) | |
Capital Surpluse | 490.0M | 490.3M | 92.5M | 132.5M | 119.2M | 113.3M | |
Property Plant Equipment | 100K | 16K | 30K | 117K | 105.3K | 100.0K | |
Net Invested Capital | 48.8M | 7.6M | 27.6M | 24.9M | 22.4M | 27.6M | |
Net Working Capital | 45.6M | 7.5M | 27.2M | 24.8M | 22.3M | 26.3M |
Pair Trading with Brickell Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brickell Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brickell Biotech will appreciate offsetting losses from the drop in the long position's value.Moving against Brickell Stock
0.85 | OPT | Opthea | PairCorr |
0.83 | ANIP | ANI Pharmaceuticals Financial Report 13th of May 2024 | PairCorr |
0.81 | PAHC | Phibro Animal Health Financial Report 1st of May 2024 | PairCorr |
0.74 | AVTE | Aerovate Therapeutics Financial Report 20th of May 2024 | PairCorr |
0.72 | CNTA | Centessa Pharmaceuticals Downward Rally | PairCorr |
The ability to find closely correlated positions to Brickell Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brickell Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brickell Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brickell Biotech to buy it.
The correlation of Brickell Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brickell Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brickell Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brickell Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brickell Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Brickell Stock analysis
When running Brickell Biotech's price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.42) | Revenue Per Share 1.94 | Quarterly Revenue Growth 27.576 | Return On Assets (0.80) | Return On Equity (1.57) |
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brickell Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.